BriaCell Therapeutics Corp. Warrant
·
BCTXZ
NASDAQ
·
Market ClosedTuesday, May 20, 2025
Change
Financial Profile
Prev Close
$1.01
Market Cap
$3.78M
Day Range
$1.02 - $1.09
Open
$1.07
52W Range
$1.02 - $1.09
24H Volume
$10.22K
Dividend Yield
0.00%
EPS
Income Statement
Revenue
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Revenue | CA$0 | $0 | $0 | $0 | $0 |
Cost of Revenue | CA$0 | $0 | $0 | $0 | $0 |
Gross Profit | CA$0 | $0 | $0 | $0 | $0 |
Gross Profit % | 0% | 0% | 0% | 0% | 0% |
R&D Expenses | CA$2.4M | $2M | $8M | $15M | $27M |
Cash Flow
Net Income
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Net Income | -CA$4M | -$14M | -$27M | -$20M | -$4.9M |
Dep. & Amort. | CA$15K | $15K | $15K | $15K | $84K |
Def. Tax | CA$0 | $0 | $0 | $0 | $0 |
Stock Comp. | CA$1.7K | $2M | $3.1M | $2.2M | $1.8M |
Chg. in WC | CA$2.7M | -$2.3M | -$391K | -$3.5M | $7.1M |
Balance Sheet
Cash
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
Cash | CA$21K | $57M | $41M | $21M | $862K |
ST Investments | CA$0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | CA$21K | $57M | $41M | $21M | $862K |
Receivables | CA$23K | $13K | $24K | $718K | $1.4M |
Inventory | CA$0 | $0 | $0 | $0 | $0 |
Related
Financial information provided by Financial Modeling Prep. Options data provided by Unusual Whales. Live transcripts provided by Quartr. Reported revenue and EPS data from Earnings powered by FinChat.io. All data is provided for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice.
- Market Cap
- $3.8M
- IPO Date
- 4/25/25
- CEO
- Dr. William V. Williams FCPA, M.D.
- Fulltime Employees
- 16
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- CA
- Exchange
- NASDAQ Global Select